Open AccessCytotoxicity Studies on Naproxen and Piroxicam Nanoformulations
Author(s) -
Sandeep Patnaik,
K Madhusudhana Rao,
Vijay Sai
Publication year - 2020
Publication title -
asian journal of pharmaceutical research and development
Language(s) - English
Resource type - Journals
ISSN - 2320-4850
DOI - 10.22270/ajprd.v8i3.754
Subject(s) - cytotoxicity , piroxicam , naproxen , viability assay , chemistry , caco 2 , in vivo , mtt assay , in vitro , pharmacology , cell , chromatography , microbiology and biotechnology , biochemistry , biology , medicine , pathology , alternative medicine
Caco-2 cells were used as in vitro models to assess the cell viability characteristics of the carriers Soluplus®, Gelucire 50/13 and PVP K25 and the nanoformulations of Naproxen and Piroxicam. The assessment of cell viability was done using the tetrazolium salt based MTT assay. Gelucire 50/13 and its NFs were observed to have slightly higher cytotoxicity than PVP and Soluplus® and their respective NFs. All the NFs were observed to follow the cytotoxicity trend of the polymers. Our results show that no significant decrease in cell viability was seen until 0.01% concentration of Gelucire 50/13 for 12-h exposure. The NFs as well as the polymers alone had no significant effect on the viability of Caco-2 cells below 0.01% concentrations. The intestine has a protective mucous layer, whereas the cell culture monolayers do not. The intestinal tissues also have more capacity to recover from trauma than the cultured cells. Hence the present NFs can be expected to show lesser cytotoxicity when subjected to in vivo studies.